Gastric Cancer-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=583965, encodeId=9b6758396532, content=老师，您好，请问这个杂志的版面费贵么nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., beContent=nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c002335043, createdName=1227ad64m36暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201934, encodeId=6fb1220193441, content=二审有under review吗？with editor多久能under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Mon May 06 08:53:30 CST 2024, time=2024-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567070, encodeId=640556e07089, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，大修后接受，编辑审稿人效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJMC3tF03dm1t2TEOSN9Hiba2iagxaIW7O4RMcQJEESwLxBY5sgv2v1eyXOZd0e7xng6eLxqp7PoSAw/132, createdBy=c2d31631094, createdName=asp, createdTime=Thu Feb 21 18:52:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183259, encodeId=5d9e218325951, content=偏重的研究方向：肿瘤 经验分享：请问一下这个期刊可以投稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef79115167, createdName=ms5000001363351337, createdTime=Mon Jan 22 19:39:14 CST 2024, time=2024-01-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153588, encodeId=9d152153588ef, content=大家几天才变成with editor呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sat Aug 19 13:53:23 CST 2023, time=2023-08-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098464, encodeId=411220984645f, content=请问certification form在哪里下载？它要求的参考文献格式是哪一种？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Nov 04 11:31:50 CST 2022, time=2022-11-04, status=1, ipAttribution=)]

2020-01-29 1227ad64m36暂无昵称

老师，您好，请问这个杂志的版面费贵么nelsontsai 2018-04-27 00:00:00 发表:
投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快.

nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快.

157 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=583965, encodeId=9b6758396532, content=老师，您好，请问这个杂志的版面费贵么nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., beContent=nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c002335043, createdName=1227ad64m36暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201934, encodeId=6fb1220193441, content=二审有under review吗？with editor多久能under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Mon May 06 08:53:30 CST 2024, time=2024-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567070, encodeId=640556e07089, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，大修后接受，编辑审稿人效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJMC3tF03dm1t2TEOSN9Hiba2iagxaIW7O4RMcQJEESwLxBY5sgv2v1eyXOZd0e7xng6eLxqp7PoSAw/132, createdBy=c2d31631094, createdName=asp, createdTime=Thu Feb 21 18:52:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183259, encodeId=5d9e218325951, content=偏重的研究方向：肿瘤 经验分享：请问一下这个期刊可以投稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef79115167, createdName=ms5000001363351337, createdTime=Mon Jan 22 19:39:14 CST 2024, time=2024-01-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153588, encodeId=9d152153588ef, content=大家几天才变成with editor呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sat Aug 19 13:53:23 CST 2023, time=2023-08-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098464, encodeId=411220984645f, content=请问certification form在哪里下载？它要求的参考文献格式是哪一种？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Nov 04 11:31:50 CST 2022, time=2022-11-04, status=1, ipAttribution=)]

2024-05-06 Jojo 来自北京

二审有under review吗？with editor多久能under review？

0 0

[GetPortalCommentsPageByObjectIdResponse(id=583965, encodeId=9b6758396532, content=老师，您好，请问这个杂志的版面费贵么nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., beContent=nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c002335043, createdName=1227ad64m36暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201934, encodeId=6fb1220193441, content=二审有under review吗？with editor多久能under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Mon May 06 08:53:30 CST 2024, time=2024-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567070, encodeId=640556e07089, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，大修后接受，编辑审稿人效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJMC3tF03dm1t2TEOSN9Hiba2iagxaIW7O4RMcQJEESwLxBY5sgv2v1eyXOZd0e7xng6eLxqp7PoSAw/132, createdBy=c2d31631094, createdName=asp, createdTime=Thu Feb 21 18:52:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183259, encodeId=5d9e218325951, content=偏重的研究方向：肿瘤 经验分享：请问一下这个期刊可以投稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef79115167, createdName=ms5000001363351337, createdTime=Mon Jan 22 19:39:14 CST 2024, time=2024-01-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153588, encodeId=9d152153588ef, content=大家几天才变成with editor呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sat Aug 19 13:53:23 CST 2023, time=2023-08-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098464, encodeId=411220984645f, content=请问certification form在哪里下载？它要求的参考文献格式是哪一种？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Nov 04 11:31:50 CST 2022, time=2022-11-04, status=1, ipAttribution=)]

2019-02-03 ms9688259418763462

审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。

158 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=583965, encodeId=9b6758396532, content=老师，您好，请问这个杂志的版面费贵么nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., beContent=nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c002335043, createdName=1227ad64m36暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201934, encodeId=6fb1220193441, content=二审有under review吗？with editor多久能under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Mon May 06 08:53:30 CST 2024, time=2024-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567070, encodeId=640556e07089, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，大修后接受，编辑审稿人效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJMC3tF03dm1t2TEOSN9Hiba2iagxaIW7O4RMcQJEESwLxBY5sgv2v1eyXOZd0e7xng6eLxqp7PoSAw/132, createdBy=c2d31631094, createdName=asp, createdTime=Thu Feb 21 18:52:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183259, encodeId=5d9e218325951, content=偏重的研究方向：肿瘤 经验分享：请问一下这个期刊可以投稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef79115167, createdName=ms5000001363351337, createdTime=Mon Jan 22 19:39:14 CST 2024, time=2024-01-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153588, encodeId=9d152153588ef, content=大家几天才变成with editor呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sat Aug 19 13:53:23 CST 2023, time=2023-08-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098464, encodeId=411220984645f, content=请问certification form在哪里下载？它要求的参考文献格式是哪一种？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Nov 04 11:31:50 CST 2022, time=2022-11-04, status=1, ipAttribution=)]

2019-02-21 asp

审稿速度:1.0 | 投稿命中率:50.0
经验分享：投了一篇，大修后接受，编辑审稿人效率高。

170 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=583965, encodeId=9b6758396532, content=老师，您好，请问这个杂志的版面费贵么nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., beContent=nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c002335043, createdName=1227ad64m36暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201934, encodeId=6fb1220193441, content=二审有under review吗？with editor多久能under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Mon May 06 08:53:30 CST 2024, time=2024-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567070, encodeId=640556e07089, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，大修后接受，编辑审稿人效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJMC3tF03dm1t2TEOSN9Hiba2iagxaIW7O4RMcQJEESwLxBY5sgv2v1eyXOZd0e7xng6eLxqp7PoSAw/132, createdBy=c2d31631094, createdName=asp, createdTime=Thu Feb 21 18:52:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183259, encodeId=5d9e218325951, content=偏重的研究方向：肿瘤 经验分享：请问一下这个期刊可以投稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef79115167, createdName=ms5000001363351337, createdTime=Mon Jan 22 19:39:14 CST 2024, time=2024-01-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153588, encodeId=9d152153588ef, content=大家几天才变成with editor呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sat Aug 19 13:53:23 CST 2023, time=2023-08-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098464, encodeId=411220984645f, content=请问certification form在哪里下载？它要求的参考文献格式是哪一种？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Nov 04 11:31:50 CST 2022, time=2022-11-04, status=1, ipAttribution=)]

2019-05-09 120cc505m10(暂无昵称)

它收纳肝癌相关的文章吗？

154 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=583965, encodeId=9b6758396532, content=老师，您好，请问这个杂志的版面费贵么nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., beContent=nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c002335043, createdName=1227ad64m36暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201934, encodeId=6fb1220193441, content=二审有under review吗？with editor多久能under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Mon May 06 08:53:30 CST 2024, time=2024-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567070, encodeId=640556e07089, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，大修后接受，编辑审稿人效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJMC3tF03dm1t2TEOSN9Hiba2iagxaIW7O4RMcQJEESwLxBY5sgv2v1eyXOZd0e7xng6eLxqp7PoSAw/132, createdBy=c2d31631094, createdName=asp, createdTime=Thu Feb 21 18:52:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183259, encodeId=5d9e218325951, content=偏重的研究方向：肿瘤 经验分享：请问一下这个期刊可以投稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef79115167, createdName=ms5000001363351337, createdTime=Mon Jan 22 19:39:14 CST 2024, time=2024-01-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153588, encodeId=9d152153588ef, content=大家几天才变成with editor呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sat Aug 19 13:53:23 CST 2023, time=2023-08-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098464, encodeId=411220984645f, content=请问certification form在哪里下载？它要求的参考文献格式是哪一种？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Nov 04 11:31:50 CST 2022, time=2022-11-04, status=1, ipAttribution=)]

2023-04-09 146afc57m84暂无昵称来自江苏省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：分子;肿瘤;基础
经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。
编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。
目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。

161 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=583965, encodeId=9b6758396532, content=老师，您好，请问这个杂志的版面费贵么nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., beContent=nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c002335043, createdName=1227ad64m36暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201934, encodeId=6fb1220193441, content=二审有under review吗？with editor多久能under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Mon May 06 08:53:30 CST 2024, time=2024-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567070, encodeId=640556e07089, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，大修后接受，编辑审稿人效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJMC3tF03dm1t2TEOSN9Hiba2iagxaIW7O4RMcQJEESwLxBY5sgv2v1eyXOZd0e7xng6eLxqp7PoSAw/132, createdBy=c2d31631094, createdName=asp, createdTime=Thu Feb 21 18:52:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183259, encodeId=5d9e218325951, content=偏重的研究方向：肿瘤 经验分享：请问一下这个期刊可以投稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef79115167, createdName=ms5000001363351337, createdTime=Mon Jan 22 19:39:14 CST 2024, time=2024-01-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153588, encodeId=9d152153588ef, content=大家几天才变成with editor呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sat Aug 19 13:53:23 CST 2023, time=2023-08-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098464, encodeId=411220984645f, content=请问certification form在哪里下载？它要求的参考文献格式是哪一种？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Nov 04 11:31:50 CST 2022, time=2022-11-04, status=1, ipAttribution=)]

2024-01-22 ms5000001363351337 来自湖北省

偏重的研究方向：肿瘤
经验分享：请问一下这个期刊可以投稿综述吗

30 0

[GetPortalCommentsPageByObjectIdResponse(id=583965, encodeId=9b6758396532, content=老师，您好，请问这个杂志的版面费贵么nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., beContent=nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c002335043, createdName=1227ad64m36暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201934, encodeId=6fb1220193441, content=二审有under review吗？with editor多久能under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Mon May 06 08:53:30 CST 2024, time=2024-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567070, encodeId=640556e07089, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，大修后接受，编辑审稿人效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJMC3tF03dm1t2TEOSN9Hiba2iagxaIW7O4RMcQJEESwLxBY5sgv2v1eyXOZd0e7xng6eLxqp7PoSAw/132, createdBy=c2d31631094, createdName=asp, createdTime=Thu Feb 21 18:52:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183259, encodeId=5d9e218325951, content=偏重的研究方向：肿瘤 经验分享：请问一下这个期刊可以投稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef79115167, createdName=ms5000001363351337, createdTime=Mon Jan 22 19:39:14 CST 2024, time=2024-01-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153588, encodeId=9d152153588ef, content=大家几天才变成with editor呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sat Aug 19 13:53:23 CST 2023, time=2023-08-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098464, encodeId=411220984645f, content=请问certification form在哪里下载？它要求的参考文献格式是哪一种？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Nov 04 11:31:50 CST 2022, time=2022-11-04, status=1, ipAttribution=)]

2023-08-19 1240adaem89暂无昵称来自四川省

大家几天才变成with editor呀？

41 0

[GetPortalCommentsPageByObjectIdResponse(id=583965, encodeId=9b6758396532, content=老师，您好，请问这个杂志的版面费贵么nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., beContent=nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c002335043, createdName=1227ad64m36暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201934, encodeId=6fb1220193441, content=二审有under review吗？with editor多久能under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Mon May 06 08:53:30 CST 2024, time=2024-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567070, encodeId=640556e07089, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，大修后接受，编辑审稿人效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJMC3tF03dm1t2TEOSN9Hiba2iagxaIW7O4RMcQJEESwLxBY5sgv2v1eyXOZd0e7xng6eLxqp7PoSAw/132, createdBy=c2d31631094, createdName=asp, createdTime=Thu Feb 21 18:52:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183259, encodeId=5d9e218325951, content=偏重的研究方向：肿瘤 经验分享：请问一下这个期刊可以投稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef79115167, createdName=ms5000001363351337, createdTime=Mon Jan 22 19:39:14 CST 2024, time=2024-01-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153588, encodeId=9d152153588ef, content=大家几天才变成with editor呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sat Aug 19 13:53:23 CST 2023, time=2023-08-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098464, encodeId=411220984645f, content=请问certification form在哪里下载？它要求的参考文献格式是哪一种？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Nov 04 11:31:50 CST 2022, time=2022-11-04, status=1, ipAttribution=)]

2022-08-10 cyfy1112@163.com

审稿速度:1.0 | 投稿命中率:75.0
经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~
很有效率

102 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=583965, encodeId=9b6758396532, content=老师，您好，请问这个杂志的版面费贵么nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., beContent=nelsontsai 2018-04-27 00:00:00 发表: 投了两篇.一篇审稿约1月拒稿.另一篇一审20天.大修.一个月厚修回.两周接收.编辑和审稿人都很nice.很快., objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c002335043, createdName=1227ad64m36暂无昵称, createdTime=Wed Jan 29 00:00:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2201934, encodeId=6fb1220193441, content=二审有under review吗？with editor多久能under review？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6fe5386329, createdName=Jojo, createdTime=Mon May 06 08:53:30 CST 2024, time=2024-05-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567070, encodeId=640556e07089, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投了一篇，大修后接受，编辑审稿人效率高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJMC3tF03dm1t2TEOSN9Hiba2iagxaIW7O4RMcQJEESwLxBY5sgv2v1eyXOZd0e7xng6eLxqp7PoSAw/132, createdBy=c2d31631094, createdName=asp, createdTime=Thu Feb 21 18:52:00 CST 2019, time=2019-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183259, encodeId=5d9e218325951, content=偏重的研究方向：肿瘤 经验分享：请问一下这个期刊可以投稿综述吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bef79115167, createdName=ms5000001363351337, createdTime=Mon Jan 22 19:39:14 CST 2024, time=2024-01-22, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2153588, encodeId=9d152153588ef, content=大家几天才变成with editor呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Sat Aug 19 13:53:23 CST 2023, time=2023-08-19, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098464, encodeId=411220984645f, content=请问certification form在哪里下载？它要求的参考文献格式是哪一种？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c9e5434372, createdName=ms6000000285996390, createdTime=Fri Nov 04 11:31:50 CST 2022, time=2022-11-04, status=1, ipAttribution=)]

2022-11-04 ms6000000285996390

请问certification form在哪里下载？它要求的参考文献格式是哪一种？

80 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务